Skip to content

Author

Alma L. Burlingame

We have 4 of 26 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Disruption of the Nav1.8/Ankyrin-3 interaction in nociceptors reduces pathological pain-like behaviors in mice.

Treating chronic neuropathic pain is challenging due to its complex pathophysiology. Persistent changes in the somatosensory system prolong heightened states of stimulus-evoked and spontaneous pain. Nociceptor dorsal root ganglion (DRG) neurons are key contributors to neuropathic pain due to pathological plasticity fol...

Rasheen Powell, Xiangsunze Zeng, B. Turnes et al. · 1 citation
Open access Sep 2026

Targeting prostaglandin catabolism via topical nanotherapy rescues vision in ischemic optic neuropathy

These findings establish 15-PGDH–mediated prostaglandin catabolism as a therapeutic target in ischemic optic neuropathy and demonstrate a clinically translatable nanotherapeutic strategy for protecting the central nervous system from ischemic neurodegeneration.

Shweta Modgil, Rusiou Hsu, M. Shariati et al. · 0 citations
Open access Aug 2026

Defining the Early Response of Oligodendrocyte-Lineage Cells to Traumatic CNS Axonal Injury

The early, traumatic injury-driven responses of the OL lineage are defined and Plin4 is identified as a novel regulator of OL lineage homeostasis, suggesting Plin4 contributes to the lipid homeostasis required for OPC differentiation and cell survival.

Yu Wu, Xiaoyun Ding, Jiaxing Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.